Global Uterine Manipulation Devices Market by End-use (ASCs, Hospitals), by Application (Total Laparoscopy Hysterectomy, Laparoscopic Supracervical Hysterectomy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global uterine manipulation device market was valued at USD 245.76 millions in 2020. It is expected to grow at a compound annual rate (CAGR of 5.6%) between 2021 and 2028. Market growth is mainly driven by the rising incidence of diseases affecting female reproductive organs and the increase in non-invasive and minimally invasive procedures. The pandemic has adversely affected the market. The COVID-19 pandemic has a significant impact on many companies' operations, product demand, supply chain, distribution system, research and development, as well as their ability to develop and market new products. Nearly all companies are affected due to COVID-19, as all hospital resources have been diverted to fight the disease.

Because of the lower risk, non-invasive and minimally invasive surgery are becoming more popular. These procedures are more popular because they require fewer incisions, which reduces postoperative pain and speeds up recovery. Laparoscopic, or robotic-assisted, hysterectomy can be used to remove the uterus. The procedure involves a small incision in the lower abdomen. A miniature camera and other specialized tools are then inserted into the area. Minimally invasive procedures are less likely to cause blood loss or infection than open surgery. Market growth is expected to be boosted by patient preference for minimally invasive treatments and the benefits provided by these techniques.

The market has seen a rise in disorders related to female reproduction in both developed and developing nations. This has prompted the development of new products. CooperSurgical, Inc., Stryker Corporation, KARL STORZ GmbH, CONMED Corporation, and Ethicon, Inc. are some of the major players in this market. Incision-free surgery is possible thanks to technological advances such as robotic-assisted or laparoscopic hysterectomy. Robotic-assisted hysterectomy offers many advantages over open abdominal hysterectomy. There are fewer complications and blood loss. It also allows for faster recovery. Robotic-assisted hysterectomy has become a common procedure in reproductive surgery due to its many advantages over open laparoscopy (open surgical). This market is expected to have a significant impact.

To increase their product ranges, manufacturing capabilities, and competitive diversity, some of the key players in the market for uterine manipulators are pursuing strategies like mergers & acquisitions or partnerships. Minerva Surgical, Inc. purchased the Intrauterine Health Products section of Boston Scientific Corporation in May 2020. These products are used to treat abnormal uterine bleeding.

Application Insights

With a 38.88% revenue share, the total laparoscopic surgery (TLH) segment was the dominant market in 2020. The procedure is used to treat conditions like fibroids, prolapse, pain in the pelvis, heavy or painful periods, precancer, cancer in the uterus or endometriosis, prolapse, and/or endometriosis. The procedure is performed in-patient and requires only one night of hospitalization. The recovery process takes between two and four weeks at home. Major abdominal hysterectomy takes longer than laparoscopic, and this is driving a rise in laparoscopic surgical preference. This segment is predicted to grow rapidly over the forecast period.

The segment of laparoscopic supracervical Hysterectomy (LSH), is expected to grow at the highest rate during the forecast period. Laparoscopic supracervical Hysterectomy (LSH), which is a minimally invasive procedure that involves the removal of a uterus, and leaving the cervical cavity in place, is another option. This procedure is used to treat uterine complications such as fibroids, endometriosis and abnormal vaginal bleeding. It also relieves pelvic pain. LSH is a partial surgery that removes the diseased uterus but preserves the cervical and ovaries. This results in less pain, fewer adhesions and a quicker recovery time than open surgery. This supports the growth of the segment.

End-use Insights

With a market share of 59.15%, hospitals dominated 2020. This segment's growth can be attributed to an increase of patients with gynecological problems and consequently a rise in the number surgical procedures. Hospitals provide superior care and reimburse for certain procedures. This is a further contributor to the segment's growth. Hospitals are also advancing technologically. Hospitals are using technologically advanced devices to offer better treatment. These devices not only simplify treatment but also provide better, faster and more accurate results.

The sector of ambulatory surgery centers is expected to grow at the highest rate during the forecast period. This segment is experiencing a high demand for outpatient surgery, an increase in minimally invasive procedures, and a cost-effectiveness for ambulatory surgery centers-based laparoscopic procedures. A booming demand will be seen for ambulatory surgery centers due to the lower risk of complications after minimally invasive laparoscopic surgeries. Patients have several benefits from ambulatory surgery centers, including faster procedure times and same-day discharge compared to hospitals. Because they are less invasive, most intra-abdominal surgeries can be done laparoscopically at ambulatory surgical centers. Ambulatory surgery centers are less expensive than inpatient procedures and require a shorter hospital stay. This reduces patient spending. The ambulatory surgery center segment is expected to grow rapidly due to the above-mentioned factors.

Regional Insights

North America was the dominant market player in 2020 with a 35.67% share. This market is expected to continue growing over the forecast period. This is due to an increasing number of gynecology related surgical procedures/hospital visits as well as the existence of a well-established healthcare infrastructure, favorable reimbursement policy, and supportive regulatory reforms within the healthcare sector. The U.S. healthcare spending increased by 4.6% to USD 3.8 trillion in 2019, which is approximately 17.7% of the country's GDP. National health spending is expected increase at an annual rate 5.4% between 2019 and 2028 to reach USD 6.8 trillion by 2028. Uterine manipulation devices are being adopted in the region due to their accessibility and strong distribution channels.

Over the forecast period, Asia Pacific is expected to experience lucrative growth. Market growth is expected to be driven by the large patient base and growing demand for cost-effective and technologically advanced healthcare solutions. The market's high-impact drivers include an increase in clinical trials and large R&D investments made by global market players in order to access untapped markets in Asia Pacific. This is due to the low cost of services. Market growth is also being supported by an increase in hospitalizations and rapid advances in the clinical development framework in developing economies.

Market Share Insights & Key Companies

To strengthen their market position, key players participate in strategies like mergers & acquisitions and partnerships. CooperSurgical Inc. purchased AEGEA Medical in February 2021. This acquisition will allow the company to expand its product line in women's healthcare. LABORIE Medical Technologies also partnered with Urotronic in October 2020. This partnership would increase the availability of minimally invasive treatments for patients with urological conditions and improve outcomes. The following are some of the major players in the global market for uterine manipulators:

• Conkin Surgical Instruments Ltd.

• Johnson and Johnson

• CooperSurgical, Inc.

• B. Braun Medical Ltd.

• KARL STORZ GmbH & Co. KG

• CONMED Corporation

• RUDOLF Medical GmbH + Company KG

• LiNA Medical ApS

• Richard Wolf GmbH

• Utah Medical Products, Inc.

• Purple Surgical

• Clinical Innovations, LLC

• Bissinger Medizintechnik

• The O.R. The O.R.

• LSI Solutions, Inc.

Up Market Research published a new report titled “Uterine Manipulation Devices Market research report which is segmented by End-use (ASCs, Hospitals), by Application (Total Laparoscopy Hysterectomy, Laparoscopic Supracervical Hysterectomy), By Players/Companies RUDOLF Medical GmbH + Co KG, The OR Company (Symmetry Surgical Inc), CooperSurgical Inc, Johnson and Johnson, Conkin Surgical Instruments Ltd, CONMED Corporation, Clinical Innovations LLC, Utah Medical Products Inc, KARL STORZ GmbH & Co KG, LiNA Medical ApS, Purple Surgical, B Braun Medical Ltd, Bissinger Medizintechnik, Richard Wolf GmbH, LSI Solutions Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Uterine Manipulation Devices Market Report Segments:

The market is segmented by End-use (ASCs, Hospitals), by Application (Total Laparoscopy Hysterectomy, Laparoscopic Supracervical Hysterectomy).

Uterine Manipulation Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Uterine Manipulation Devices Market

Overview of the regional outlook of the Uterine Manipulation Devices Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Uterine Manipulation Devices Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Uterine Manipulation Devices Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. ASCs

                2. Hospitals

                1. Total Laparoscopy Hysterectomy

                2. Laparoscopic Supracervical Hysterectomy

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Uterine Manipulation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Uterine Manipulation Devices Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.